CFR Pharmaceuticals Considers Possible Acquisitions


News: Chilean drugmaker CFR Pharmaceuticals is assessing acquisitions of medium sized and family businesses in Mexico. CEO Alejandro Weinstein said that 'Mexico is like a continent and we see a great opportunity to build medium-sized companies there,' reports El Financiero. The company will focus on three areas of the Mexican pharmaceutical market: generic drugs, private labels and sales to institutions.

This article is tagged to:
Related sectors of this article: Pharmaceuticals & Healthcare, M&A
Geography: Chile, Mexico

Access all of our latest analysis, data and forecasts - request a trial